24 May 2019
Chemicals compliance
The European Commission has opened a "call for data" for 14 substances identified as endocrine disruptors used in cosmetic products, in order to protect human health as required by Regulation 1223/2009.
The SCCS will evaluate potentially dangerous substances on a case-by-case basis.
The Commission has identified a list of substances with higher priorities such as:
|
INCI Name |
CAS No. |
|
Benzophenone-3 |
131-57-7 |
|
Kojic acid |
501-30-4 |
|
4-Methylbenzylidene camphor |
36861-47-9 |
|
Propylparaben |
94-13-3 |
|
Triclosan |
3380-34-5 |
|
Resorcinol |
108-46-3 |
|
Octocrylene |
6197-30-4 |
|
Triclocarban |
101-20-2 |
|
BHT (butylated hydroxytoluene) |
128-37-0 |
|
Benzophenone |
119-61-9 |
|
Homosalate |
118-56-9 |
|
Benzyl salicylate |
118-58-1 |
|
Genistein |
446-72-0 |
|
Daidzein |
486-66-8 |
Interested companies can submit the following relevant information by October 15, 2019:
The transmission methods are:
The information can be sent to the following address:
European Commission
Directorate General Internal Market, Industry, Entrepreneurship and SMEs
Unit D / 4, Health Technology and Cosmetics
Avenue d’Auderghem 45, BREY 12/10
B-1040 Brussels
Email: grow-cosmetics-and-medical-devices@ec.europa.eu
04 April 2024
Chemicals compliance
On 3 April 2024, Regulation 2024/996 amending Annexes II, III, V and VI of Regulation (EC) No 1223/2009 was published. Below is the list of the amendments: Annex II (prohibited substances): the substance...
18 March 2024
Chemicals compliance
On 15 March 2024, Regulation 2024/858 was published, amending Annexes II and III of Regulation 1223/2009 with regard to certain nanomaterials. The following have been added to Annex II (and are therefore...